1-9 of 9
Tressa Hood
Close
Sort by
Journal Articles

The Combination of Lanraplenib, a Selective SYK Inhibitor, and Gilteritinib, a FLT3 Inhibitor, Targets Aberrant Proliferation and Differentiation Blockade in Acute Myeloid Leukemia

Luis A. Carvajal, Michael R. McKeown, Tressa Hood, Linlin Guo, Charles Y. Lin, Jorge F. DiMartino
Journal: Blood
Blood (2023) 142 (Supplement 1): 5951.
https://doi.org/10.1182/blood-2023-186605
Published: 2023
Journal Articles

The Novel Profiling Relative Inhibition Simultaneously in Mixtures (PRISM) Platform Identifies Synergistic Activity of Lanraplenib and Ruxolitinib in Hematological Malignancies

Akanksha Pandey, Luis A. Carvajal, Andrew S Boghossian, Matthew G Rees, Melissa M Ronan, Jennifer A Roth, Tressa Hood, Linlin Guo, Tamara D Hopkins, Nikolaus Obholzer, Michael R. McKeown, Jorge F. DiMartino, Charles Y. Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2259.
https://doi.org/10.1182/blood-2023-174114
Published: 2023
Journal Articles

Development of a Standardized, DNA-Based Next Generation Sequencing Assay for Assessment of Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML) As the Primary Endpoint in the Agility Study

Luis A. Carvajal, Tressa Hood, Yana Bevan, Richard Dillon, Nicola Potter, Ian Thomas, Sean Johnson, Jad Othman, Amanda Gilkes, Nigel H. Russell, Adam Sikorski, Pete Ellis, Giovanni Marsico, Greg Jones, Crystal MacKenzie, Zung To, Jorge DiMartino, Pavan Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 3377–3378.
https://doi.org/10.1182/blood-2022-159154
Published: 2022
Journal Articles

SYK Inhibitors, Entospletinib and Lanraplenib, Show Potent Anti-Leukemic Activity in Combination with Targeted Agents

Luis A. Carvajal, Michael McKeown, Tressa Hood, Pavan Kumar, Douglas C. Saffran, Jorge DiMartino
Journal: Blood
Blood (2022) 140 (Supplement 1): 5932–5933.
https://doi.org/10.1182/blood-2022-159087
Published: 2022
Journal Articles

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Jayakumar Vadakekolathu, PhD, Mark D. Minden, MD PhD, Tressa Hood, MSc, Sarah E. Church, PhD, Stephen Reeder, BSc, Heidi Altmann, PhD, Amy H Sullivan, BSc, Elena J Viboch, MSc, Tasleema Patel, Narmin Ibrahimova, Sarah E. Warren, PhD, Andrea Arruda, Marc Schmitz, MD, Yan Liang, PhD, Alessandra Cesano, MD PhD, A. Graham Pockley, PhD, Peter Valk, PhD, Bob Löwenberg, MD PhD, Martin Bornhäuser, MD, Sarah K. Tasian, MD, Michael P. Rettig, PhD, Jan K Davidson-Moncada, MD PhD, John F. DiPersio, MD PhD, Sergio Rutella, MDPhDFRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 460.
https://doi.org/10.1182/blood-2019-121870
Published: 2019
Journal Articles

Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 × CD3 Bispecific Dart ® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Sergio Rutella, MD PhD FRCPath, Sarah E. Church, PhD, Jayakumar Vadakekolathu, PhD, Elena Viboch, MSc, Amy H Sullivan, BSc, Tressa Hood, MSc, Sarah E. Warren, PhD, Alessandra Cesano, MD PhD, Ross La Motte-Mohs, PhD, John Muth, MS, Helene Lelièvre, PhD PharmD, Bob Lowenberg, MD, John F. DiPersio, MD PhD, Jan K Davidson-Moncada, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 444.
https://doi.org/10.1182/blood-2018-99-111539
Published: 2018
Journal Articles

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

Jayakumar Vadakekolathu, PhD, Tasleema Patel, BSc, Stephen Reeder, BSc, Heidi Schaarschmidt, BSc, Marc Schmitz, MD, Martin Bornhäuser, MD, Sarah E. Warren, PhD, Tressa Hood, MS, Patrick Danaher, PhD, Alessandra Cesano, Joseph M. Beechem, PhD, A. Graham Pockley, PhD, Sarah K Tasian, MD, Sergio Rutella, MDPhDFRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 3942.
https://doi.org/10.1182/blood.V130.Suppl_1.3942.3942
Published: 2017
Journal Articles

Analytical Validation of the nCounter ® -based Lymphoma Subtyping Test (LST) for Cell-of-Origin (COO) Identification in Formalin-Fixed Paraffin-Embedded (FFPE) Diffuse Large B-Cell Lymphoma (DLBCL) Specimens

Ning Chen, Shannon Dennis, Patrick Danaher, Brett Wallden, Tressa Hood, Xing Ren, Mingdong Liu, Naeem Dowidar, Amy Sullivan, Taryn Haffner, Alessandra Cesano, Sean Ferree, James Storhoff
Journal: Blood
Blood (2016) 128 (22): 2933.
https://doi.org/10.1182/blood.V128.22.2933.2933
Published: 2016
Journal Articles

Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples

James Storhoff, Brett Wallden, Rita M. Braziel, Catherine Thieblemont, Tressa Hood, Harini Ravi, Shannon Dennis, Naeem Dowidar, Patrick Danaher, Jennifer Dunlap, MD, Josette Briere, Eric de Kerviler, Sean Ferree
Journal: Blood
Blood (2015) 126 (23): 1481.
https://doi.org/10.1182/blood.V126.23.1481.1481
Published: 2015